Trial intelligence / Profile preview

Berberine in Type 2 Diabetes With Dyslipidemia

NCT00462046Phase 3Completed

Sponsor
Shanghai Jiao Tong University School of Medicine
Start
Apr 2005
Modality
Small Molecules
01

Overview

A Phase 3 trial of berberine in type 2 diabetes mellitus (T2DM), dyslipidemia, sponsored by Shanghai Jiao Tong University School of Medicine. Started Apr 2005; status: completed.

02

Drugs

berberine
03

Conditions

type 2 diabetes mellitus (T2DM)dyslipidemia

Beyond the preview

Go deeper on NCT00462046.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00462046.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call